Immatics N.V. Ordinary Shares
IMTX
IMTX: Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
moreShow IMTX Financials
Recent trades of IMTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by IMTX's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on IMTX's company Twitter account
Number of mentions of IMTX in WallStreetBets Daily Discussion
Recent insights relating to IMTX
Recent picks made for IMTX stock on CNBC
ETFs with the largest estimated holdings in IMTX
Flights by private jets registered to IMTX